Oncolytic Immunotherapy

Dr. Merrick Ross outlines the expanding role of oncolytic immunotherapy in the treatment of melanoma.


August 16, 2021

Created by

Scripps CME Connection

Related Presenters

Merrick Ross, MD

Merrick Ross, MD

Professor, Department of Surgical Oncology, Chief, Melanoma Section
Charles M. McBride Distinguished Chair, Department of Surgical Oncology
UT MD Anderson Cancer Center

Dr. Merrick I. Ross received his medical degree from the University of Illinois School of Medicine in Chicago, and completed a residency in general surgery at the University of Illinois Affiliated Hospitals in Chicago.

View full profile